Filter by:
This overview describes and evaluates the current crack cocaine situation in Île-de-France in order, in particular, to improve the treatment of users and, more generally, the response of the public authorities to a phenomenon that has been identified for around thirty years.
The introduction of lockdown measures by the public authorities between 17 March and 11 May 2020 in response to the Covid-19 pandemic in France yielded dramatic changes in consumption practices of cannabis users.
Based mainly on data published by the WHO, this note aims to provide an overview of the main legislative and regulatory measures taken by the different EU countries to reduce harmful alcohol consumption.
Bulletin TREND | COVID-19 n°2. The development of the COVID-19 epidemic and the implementation of lockdown measures by the French public authorities in mid-March 2020 changed the consumption practices of drug users and disrupted the activities of trafficking networks.
Bulletin TREND | COVID-19 n°1. The development of the COVID-19 epidemic and the implementation of lockdown measures by the French public authorities in mid-March 2020 changed the consumption practices of a large proportion of drug users and disrupted the activities of trafficking networks.
The 2019 edition of the annual OFDT overview on tobacco describes the repercussions of successive rises in prices of tobacco in the tobacconist network and the continuous increase of the number of people following a treatment to stop smoking.
In 2017, in order to contribute to reflection on so-called "substance-free" addictions among adolescents, the French Monitoring Centre for Drugs and Drug Addiction (OFDT) integrated a new module on the use of various electronic devices with screens into its Survey on Health and Use on National Defence and Citizenship Day (ESCAPAD).
This briefing paper describes the regulatory models that have been implemented since 2014 in the American states that have legalised cannabis, highlighting their differences and similarities. It also discusses the reform processes and common features of states that have legalised cannabis for medical and recreational use.
In the wake of the 2017 findings, the year 2018 was marked by a sharp decline in cigarette and of roll-your-own tobacco sales in France's tobacconist network. However, a slight increase in other types of tobacco, less heavily taxed, can be seen, together with a likely increase in cross-border purchases.
Following Uruguay in 2013, Canada is the second country in the world - the first in G7 - that has officially legalised the production, distribution and possession of cannabis for recreational use.
The downward trend in official tobacco sales observed in 2016 has been confirmed in 2017 (characterised by a very powerful symbolic measure, plain packaging) with the marked decline in roll-your-own tobacco owing to its lower price.
In the 2000s, a new method was developed for estimating psychoactive substance use: testing drug residues in sewage. Ten or so years later, this innovative method, sewage epidemiology, is now applied in numerous countries.
Although cannabis is still prohibited at federal level, 8 American states and the District of Columbia have made unprecedented changes to their cannabis regulations with the legalisation of cultivation, sale, possession and use of cannabis for non-medical (i.e. recreational) purposes from the age of 21.
Since April 2004, the French Monitoring Centre for Drugs and Drug Addiction (OFDT) has been compiling various key indicators each month as part of a "review on tobacco".
This briefing is structured in three parts. It first presents the international legislative framework established by the United Nations and the European Union and laid down in three treaties: the 1961 Single Convention on Narcotic Drugs (amended by the 1972 protocol), the 1971 Convention on Psychotropic Substances and the 1988 Convention Against Illicit Traffic in Narcotic Drugs and…
The laws governing cannabis use, tolerated in some countries yet totally banned in others, vary significantly from one European Union country to another.
For the first time since 2010, French tobacco retailer sales have risen considerably, in a context where tobacco prices were not increased in France in 2015, and cross-border purchases generally appeared stable.
Studies on social cost allow public authorities to evaluate the economic burden of a social problem on the community.
The use of morphine sulphate outside of the scope of the therapeutic framework is not a new phenomenon. However, starting in 2000 and for a decade thereafter, such use appeared to be fairly controlled, geographically-contained and volatile over time. Since 2011 or so, there has been a rise in demand that is disparate, but geographically widespread.
This briefing produced by the OFDT's TREND (Emerging trends and new drugs) Unit focuses on ketamine, a veterinary and human anaesthetic.
